Physiologically Based Pharmacokinetic Modeling of Nanoparticles.
Physiologically Based Pharmacokinetic Modeling of Nanoparticles.
复制标题
DOI:
10.1016/j.xphs.2018.10.037
复制
发表时间:
2019-01
影响因子:
3.8
通讯作者:
Cao Y
中科院分区:
文献类型:
--
作者:
Yuan D;He H;Wu Y;Fan J;Cao Y
Nanoparticles are frequently designed to improve the pharmacokinetics profiles and tissue distribution of small molecules in order to prolong their systemic circulation, target specific tissue, or widen the therapeutic window. The multi-functionality of nanoparticles is frequently presented as an advantage but also results in distinct and complicated in vivo disposition properties compared to a conventional formulation of the same molecules. Physiologically-based pharmacokinetic (PBPK) modeling has been a useful tool in characterizing and predicting the systemic disposition, target exposure, and efficacy/toxicity of various types of drugs when coupled with pharmacodynamics (PD) modeling. Here, we review the unique disposition characteristics of nanoparticles, assess how PBPK modeling takes into account the unique disposition properties of nanoparticles, and comment on the applications and challenges of PBPK modeling in characterizing and predicting the disposition and biological effects of nanoparticles.
登录
查看更多内容
DOI:
10.1186/2193-9616-1-8
发表时间:
2013
期刊:
In silico pharmacology
影响因子:
--
作者:
Quignot N
通讯作者:
Quignot N
影响因子:
14
作者:
He, Zhijian;Wan, Xiaomeng;Schulz, Anita;Bludau, Herdis;Dobrovolskaia, Marina A.;Stern, Stephan T.;Montgomery, Stephanie A.;Yuan, Hong;Li, Zibo;Alakhova, Dania;Sokolsky, Marina;Darr, David B.;Perou, Charles M.;Jordan, Rainer;Luxenhofer, Robert;Kabanov, Alexander V.
通讯作者:
Kabanov, Alexander V.
影响因子:
17.4
作者:
Gustafson HH;Holt-Casper D;Grainger DW;Ghandehari H
通讯作者:
Ghandehari H
影响因子:
5
作者:
Bachler, Gerald;von Goetz, Natalie;Hungerbuhler, Konrad
通讯作者:
Hungerbuhler, Konrad
影响因子:
2
作者:
Hashimoto, Yosuke;Shimizu, Taro;Kiwada, Hiroshi
通讯作者:
Kiwada, Hiroshi